 | Study programme 2021-2022 | Français | |
 | Développement pharmaceutique | ||
Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-033-M | Optional UE | VANDERBIST Francis | M111 - Pharmacie Galénique |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-233 | Développement pharmaceutique | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
Pharmaceutical Development
The objective of this lesson is to expose the main lines of the way a pharmaceutical development of a drug occurs.
The lesson describes and explains the development of a pharmaceutical drug from the earliest steps (preformulation) to the obtention of the final form of the drug at the industrial scale.
A special attention is paid to the possible mistakes or lack of knowledge during development and to identify the key parameters allowing the obtention of a robust and reproducible pharmaceutical form.
The lesson describes some real cases of different various forms.
Content of UE
Content of the UE (10h) : Pharmaceutical Development
The objective of this lesson is to expose the main lines of the way a pharmaceutical development of a drug occurs.
The lesson describes and explains the development of a pharmaceutical drug from the earliest steps (preformulation) to the obtention of the final form of the drug at the industrial scale.
A special attention is paid to the possible mistakes or lack of knowledge during development and to identify the key parameters allowing the obtention of a robust and reproducible pharmaceutical form.
The lesson describes some real cases of different various forms.
Prior Experience
good knowledge of galenic and pharmaceutical technology
Type of Assessment for UE in Q1
- Oral examination
Q1 UE Assessment Comments
non-applicable
Type of Assessment for UE in Q3
- N/A
Q3 UE Assessment Comments
non-applicable
Type of Resit Assessment for UE in Q1 (BAB1)
- N/A
Q1 UE Resit Assessment Comments (BAB1)
non-applicable
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-233 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-233 |
|
Required Reading
| AA | |
|---|---|
| M-DOYM-233 |
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-233 | Not applicable |
Recommended Reading
| AA | |
|---|---|
| M-DOYM-233 |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-233 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-233 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-DOYM-233 | Authorized |